Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedApr 02, 2026
DataAggregated Company Financials
Companies5
  • 7D4.7%
  • 3M-16.3%
  • 1Y17.0%
  • YTD-15.5%

All of the companies in the Biotech industry have been up over the last week, with the industry up 3.9%. In the last 12 months, the industry was up 12%. Earnings are forecast to grow by 1.6% annually.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 02 Apr 2026DKK 144.6bDKK 39.5bDKK 14.0b11x10.4x3.7x
Sat, 28 Feb 2026DKK 155.3bDKK 39.6bDKK 14.9b6.3x10.4x3.9x
Mon, 26 Jan 2026DKK 177.3bDKK 40.4bDKK 18.9b6.3x9.4x4.4x
Wed, 24 Dec 2025DKK 180.1bDKK 40.5bDKK 18.9b6.1x9.5x4.4x
Fri, 21 Nov 2025DKK 174.1bDKK 41.0bDKK 19.2b6x9.1x4.2x
Sun, 19 Oct 2025DKK 180.0bDKK 38.9bDKK 16.8b13.1x10.7x4.6x
Tue, 16 Sep 2025DKK 158.5bDKK 38.7bDKK 16.7b12.6x9.5x4.1x
Thu, 14 Aug 2025DKK 131.9bDKK 29.6bDKK 8.8b12.1x15x4.5x
Sat, 12 Jul 2025DKK 127.6bDKK 26.9bDKK 7.3b11.3x17.4x4.7x
Mon, 09 Jun 2025DKK 137.5bDKK 27.5bDKK 7.5b11.3x18.3x5x
Wed, 07 May 2025DKK 132.1bDKK 27.3bDKK 7.7b11.7x17.2x4.8x
Fri, 04 Apr 2025DKK 126.8bDKK 27.3bDKK 7.7b11.2x16.5x4.6x
Sun, 02 Mar 2025DKK 162.8bDKK 27.7bDKK 7.8b12.4x20.8x5.9x
Tue, 28 Jan 2025DKK 166.7bDKK 26.0bDKK 4.7b16.9x35.5x6.4x
Thu, 26 Dec 2024DKK 160.6bDKK 26.0bDKK 4.7b16.6x34.2x6.2x
Sat, 23 Nov 2024DKK 161.9bDKK 26.0bDKK 4.7b17x34.5x6.2x
Mon, 21 Oct 2024DKK 174.2bDKK 25.5bDKK 5.5b21x31.8x6.8x
Wed, 18 Sep 2024DKK 197.7bDKK 25.5bDKK 5.5b23.7x36.1x7.8x
Fri, 16 Aug 2024DKK 203.1bDKK 26.0bDKK 5.7b20.1x35.6x7.8x
Sun, 14 Jul 2024DKK 197.3bDKK 24.8bDKK 5.6b17.7x35x8x
Tue, 11 Jun 2024DKK 179.2bDKK 24.8bDKK 5.6b18.3x31.8x7.2x
Thu, 09 May 2024DKK 183.7bDKK 25.2bDKK 6.2b16.1x29.8x7.3x
Sat, 06 Apr 2024DKK 186.1bDKK 23.9bDKK 5.0b19.4x36.9x7.8x
Mon, 04 Mar 2024DKK 184.8bDKK 22.8bDKK 4.3b23.5x43.2x8.1x
Wed, 31 Jan 2024DKK 169.7bDKK 23.3bDKK 4.2b23.2x40.8x7.3x
Fri, 29 Dec 2023DKK 178.0bDKK 23.3bDKK 4.2b26.1x42.8x7.6x
Sun, 26 Nov 2023DKK 172.7bDKK 23.3bDKK 4.2b25x41.5x7.4x
Tue, 24 Oct 2023DKK 163.5bDKK 22.0bDKK 4.7b19x34.5x7.4x
Thu, 21 Sep 2023DKK 202.0bDKK 22.0bDKK 4.7b23.8x42.7x9.2x
Sat, 19 Aug 2023DKK 187.2bDKK 20.6bDKK 3.9b35.3x48.5x9.1x
Mon, 17 Jul 2023DKK 200.5bDKK 19.5bDKK 4.4b40.9x45.5x10.3x
Wed, 14 Jun 2023DKK 207.7bDKK 19.5bDKK 4.4b44.9x47.1x10.6x
Fri, 12 May 2023DKK 218.2bDKK 17.9bDKK 4.1b33.9x53.3x12.2x
Sun, 09 Apr 2023DKK 199.2bDKK 17.9bDKK 3.5b31x56.3x11.1x
Price to Earnings Ratio

56.3x


Total Market Cap: DKK 199.2bTotal Earnings: DKK 3.5bTotal Revenue: DKK 17.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 29.5x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 10.1x which is lower than its 3-year average PE of 29.5x.
  • The 3-year average PS ratio of 6.7x is higher than the industry's current PS ratio of 3.6x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have grown 58% per year over the last three years.
  • Revenues for these companies have grown 30% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market2.96%
Healthcare1.51%
Biotech4.68%
Biotech4.68%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GMAB GenmabDKK 1.76k5.1%
+DKK 5.3b		37.9%PE17.4x
ZEAL Zealand PharmaDKK 298.003.6%
+DKK 727.4m		-36.0%PE3.3x
BAVA Bavarian NordicDKK 195.703.0%
+DKK 440.8m		29.6%PE11x
BIOPOR BioPortoDKK 0.893.4%
+DKK 14.4m		-38.3%PS10.9x
STRAP Strategic PartnersDKK 608.008.6%
+DKK 2.0m		-33.4%PB1.4x

Latest News

BIOPOR
DKK 0.89
BioPorto
7D
3.4%
1Y
-38.3%
GMAB
DKK 1,758.50
Genmab
7D
5.1%
1Y
37.9%

GMAB: 2026 Late Stage Oncology Catalysts Will Support Stronger Margin Profile

Genmab's updated analyst price target now sits at DKK 3,017, a modest reset from DKK 3,060 as analysts factor in higher discount rates, revised long term margin expectations, and recent research that reflects both increased revenue growth assumptions and a lower future P/E multiple. Analyst Commentary Recent Street research around Genmab has centered on how new clinical and portfolio developments filter into valuation, with several bullish analysts updating price targets and investment cases to reflect revised expectations on execution and long term growth potential.
BAVA
DKK 195.70
Bavarian Nordic
7D
3.0%
1Y
29.6%
ZEAL
DKK 298.00
Zealand Pharma
7D
3.6%
1Y
-36.0%
STRAP
DKK 608.00
Strategic Partners
7D
8.6%
1Y
-33.4%